1 RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
2 Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.
3 Adelaide Centre for Epigenetics, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
4 South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
5 Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
6 Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
7 Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine and Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, China.
8 Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia.
9 University of Basel, Basel, Switzerland.
10 Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au.
11 Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au.
12 Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au.
13 RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. vi.wickramasinghe@petermac.org.
14 Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia. vi.wickramasinghe@petermac.org.